Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Akamis Bio is a clinical-stage oncology company.
Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Renalys Pharma is a clinical-stage biopharmaceutical company developing therapeutics for renal disease in Asian patients.
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
SR One has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
SR One's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Life Science. The firm invests across 11 different industry categories.
Among tracked funding rounds, Alumis received $345.1M in a Post Ipo Equity round. SR One's total known invested capital is $4.4B.
SR One's average investment size is $105.1M across its portfolio of 65 companies.
Recent SR One portfolio additions include Addition Therapeutics, HotSpot Therapeutics, Arcellx, CORXEL Pharmaceuticals, AirNexis Therapeutics. These companies were founded in 2020 or later.